Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6949-6949
Open Access | Times Cited: 23

Showing 23 citing articles:

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
Jorge Gutiérrez‐Cuevas, Arturo Santos, Juan Armendáriz‐Borunda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 143
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD
Devaraj Ezhilarasan
Metabolism (2024) Vol. 155, pp. 155912-155912
Closed Access | Times Cited: 9
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7
Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
Tanmoy Banerjee, Arnab Sarkar, Sk Zeeshan Ali, et al.
Planta Medica (2024) Vol. 90, Iss. 09, pp. 675-707
Open Access | Times Cited: 5
Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
Madan Kumar Arumugam, Thiyagarajan Gopal, Rakhee Rathnam Kalari Kandy, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1311-1311
Open Access | Times Cited: 14
Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease
Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale
Metabolites (2023) Vol. 13, Iss. 3, pp. 322-322
Open Access | Times Cited: 9
Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease.
Dmitry Victorovich Garbuzenko
PubMed (2022) Vol. 15, Iss. 3, pp. 194-203
Closed Access | Times Cited: 12
Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System
Rossella D’Oria, Valentina Annamaria Genchi, Cristina Caccioppoli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14296-14296
Open Access | Times Cited: 12
Common Denominator of MASLD and Some Non-Communicable Diseases
Katarzyna Ferenc, Sara Jarmakiewicz-Czaja, Aneta Sokal, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6690-6709
Open Access | Times Cited: 1
Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review
Pramod Patidar, Nik Hirani, Shreya Bharti, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112938-112938
Closed Access | Times Cited: 1
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
Jiajun Qiu, Maobin Kuang, Ruijuan Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Frizzled receptors and SFRP5 in lipid metabolism: Current findings and potential applications
Dinh‐Toi Chu, Thanh-Lam Nguyen
Progress in molecular biology and translational science (2022), pp. 377-393
Closed Access | Times Cited: 5
An Update on the Risk Factors Correlating NAFLD with Cardiovascular Disease: Specifically Mitochondrial - Fatty Acids β Oxidation in Liver with Therapeutic Approaches of Avoidance of CVD Associated Mortality-A Systematic Review
Kulvinder Kochar Kaur
Open Access Journal of Endocrinology (2022) Vol. 6, Iss. 1
Closed Access | Times Cited: 4
A high-fat diet increases hepatic mitochondrial turnover through restricted acetylation in a NAFLD mouse model
Mirjavid Aghayev, Andrea Arias-Alvarado, Sergei A. Ilchenko, et al.
AJP Endocrinology and Metabolism (2023) Vol. 325, Iss. 1, pp. E83-E98
Closed Access | Times Cited: 2
Steamed daylily flower (Hemerocallis fulva L.) protected cardiac and hepatic cells against ethanol induced apoptotic and oxidative damage
Sheng‐Lei Yan, Wen‐Tzu Wu, Mei‐Chin Mong, et al.
Journal of Food and Drug Analysis (2023) Vol. 31, Iss. 4
Open Access | Times Cited: 2
Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials
Hongshuai Liu, Yufei Li, Jin Yan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3801-3824
Closed Access
SIRT1 Controls Lipid Metabolism Under Physiological and Pathological Conditions: Implications in Atherosclerosis
Anastasia V. Poznyak, Л. В. Недосугова, Victoria A. Khotina, et al.
OnLine Journal of Biological Sciences (2024) Vol. 24, Iss. 4, pp. 584-596
Open Access
Short‐term exercise counteracts accelerated ageing impacts on physical performance and liver health in mice
Ana P. Pinto, Vitor Rosetto Muñoz, Maria Eduarda Almeida Tavares, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 12
Open Access
Association between atherosclerosis and the development of multi-organ pathologies
Siarhei A. Dabravolski, Alexey V. Churov, Natalia V. Elizova, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access
Drug-based approaches to modulate mitochondrial condition in the case of atherosclerosis: focus on correction of mitochondria dysfunction
Darina Gavrilova, Evgeny E. Bezsonov, Tatyana Degtyarevskaya
Journal of Translational Genetics and Genomics (2023) Vol. 7, Iss. 4, pp. 236-58
Open Access | Times Cited: 1
Pharmacological agents affecting mitophagy and inflammation
Evgeny E. Borisov, Evgeny E. Bezsonov, D. Lyukmanov, et al.
Vessel Plus (2022) Vol. 6, pp. 63-63
Open Access | Times Cited: 2
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Clinical Evidence and a Mechanistic Review
飏 屈
Advances in Clinical Medicine (2023) Vol. 13, Iss. 08, pp. 12753-12764
Closed Access
Asociación entre tejido adiposo abdominal, esteatosis hepática y grasa epicárdica con placas coronarias evaluadas por angiotomografía en hospital de tercer nivel de Ecuador
Fabiola Elizabeth Larriva Villareal
(2022)
Open Access
Page 1

Scroll to top